Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in men worldwide. This slow-growing, hormone-sensitive cancer occurs after the age of 50 years. Cervical lymph node metastases of prostate adenocarcinoma are rare. We report two anatomical observations over a ten-year period of activity. The two men were aged 80 and 72 years, respectively, and both presented with multiple cervical adenopathies of particular topography above the clavicle, associated with urinary signs such as dysuria, pollakiuria and incontinence. Microscopic examination coupled with immunohistochemistry (anti-PSA antibodies) of the excised biopsy of these lymph nodes contributed to the diagnosis of certainty. Keywords: Adenocar...
Prostate is cancer is the most commonly diagnosed cancer in men worldwide and the second biggest kil...
AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Aims:Patients presenting with a neck mass are commonly seen by the ENT surgeon. They are also usual...
Prostate carcinoma is one of the most common cancers in males all around the world. Head and neck sq...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Prostate cancer usually metastasis to the regional lymph nodes and can rarely metastases to nonregio...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Three patients with prostate cancer and left cervical lymph node metastasis are presented. The three...
We present two patients with metastasis of a prostate carcinoma in the mesorectal lymphatic nodes. A...
AbstractWe present two patients with metastasis of a prostate carcinoma in the mesorectal lymphatic ...
Adenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age; this a...
Prostate is cancer is the most commonly diagnosed cancer in men worldwide and the second biggest kil...
AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Aims:Patients presenting with a neck mass are commonly seen by the ENT surgeon. They are also usual...
Prostate carcinoma is one of the most common cancers in males all around the world. Head and neck sq...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Prostate cancer usually metastasis to the regional lymph nodes and can rarely metastases to nonregio...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Three patients with prostate cancer and left cervical lymph node metastasis are presented. The three...
We present two patients with metastasis of a prostate carcinoma in the mesorectal lymphatic nodes. A...
AbstractWe present two patients with metastasis of a prostate carcinoma in the mesorectal lymphatic ...
Adenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age; this a...
Prostate is cancer is the most commonly diagnosed cancer in men worldwide and the second biggest kil...
AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...